Capital Raising
•
M&A
•
Strategic Advisory
Biotech
MedTech
Diagnostics
Life Science Tools
STRATEGIC ADVISORY
U.S. Therapeutics Company
Equity story, strategic positioning & investor materials etc.
Biotech
|
2026
PRIVATE PLACEMENT
totalling USD 26m
Life Science Tools
|
2024
DIRECTED SHARE ISSUE
totalling USD 19m
Two equity financings: Directed share issues + repair issue
Biotech
|
2023 / 2024
01
Capital Raising
Public & private equity financing strategy, investor positioning and execution.
02
Strategic Transactions
M&A, partnerships and strategic alternatives, from evaluation to execution.
03
Strategic Advisory
Senior counsel on strategy, financing and other critical corporate decisions.
Deep life science expertise
Therapeutics
From early-stage innovation to late-stage value creation across modalities.
Medical Technology
Advising companies across devices, platforms and clinical technologies.
Diagnostics
Supporting companies across diagnostics, detection and precision medicine.
Life Science Tools
Advising companies enabling research, discovery and drug development.
Adam Karlsson
Partner
MBBS, MPhil, CFA
Rickard Anderkrans
Partner
MSc Accounting & Finance
Jonas Hansson
Partner
MSc Pharm, MBA
Jacob Gunterberg
Partner
MSc BA & Economics
At a defining moment?
Let’s talk.
Get in touch →